Suchergebnisse - "Systemic lupus erythematosus"

PubPharm (399)

101

Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome : Using the Objective Measurement Methods and TCM Questionnaire to Explore the Association Among TCM Pattern, TCM Tongue Diagnosis and TCM Pulse Diagnosis for Autoimmune Disease and Dry Eye Syndrome

enthalten in: ClinicalTrials.gov | 2021

102

Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus : An Open-label Study for Assessing the Efficacy and Safety of Nicotinamide Treatment for Lupus-associated Skin Lesions in Patients With Cutaneous Lupus Erythematosus or Systemic Lupus Erythematosus

enthalten in: ClinicalTrials.gov | 2021

103

Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells : Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Olfactory Mucosa Derived Mesenchymal Stem Cells

enthalten in: ClinicalTrials.gov | 2021

104

Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease : Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease

enthalten in: ClinicalTrials.gov | 2021

105

Systemic lupus erythematosus

Erschienen: Amsterdam, Academic Press, 2021

Sixth edition

von Lahita, R.

106

Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects : An Open-label, Randomized, Parallel Group, Single Dose Study to Investigate the PK and Safety of Belimumab 200 mg Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Participants

enthalten in: ClinicalTrials.gov | 2020

107

A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) : A Randomised, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of Ocrelizumab in Patients With WHO or ISN Class III or IV Nephritis Due to Systemic Lupus Erythematosus

enthalten in: ClinicalTrials.gov | 2020

108

Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe : Prevalence, Seroconversion and Impact of COVID-19 in Autoimmune Diseases in Europe

enthalten in: ClinicalTrials.gov | 2020

109

Belimumab in Patients With Systemic Lupus Erythematosus : Effectiveness, Tolerability, and Safety of Belimumab in Patients With Systemic Lupus Erythematosus Treated at the Spanish Departments of Internal Medicine

enthalten in: ClinicalTrials.gov | 2020

110

Transcriptional and Immine Parameters of Response to Belinumab : Whole Blood Transcriptional and Mass Cytometry Immune Profiling in Systemic Lupus Erythematosus (SLE) Patients to Discern the Salutary Effects of Belimumab on Halting Disease Progression and Flares Without Compromising Host Fitness

enthalten in: ClinicalTrials.gov | 2020